Vascular factors in cognitive impairment--where are we now?
about
Inhibition of topoisomerase I cleavage activity by thiol-reactive compounds: importance of vicinal cysteines 504 and 505The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamilyIdentification and characterization of a melanin-concentrating hormone receptorRho family Guanine nucleotide exchange factor Brx couples extracellular signals to the glucocorticoid signaling systemNoradrenergic depression of neuronal excitability in the entorhinal cortex via activation of TREK-2 K+ channels.Remote control of renal physiology by the intestinal neuropeptide pigment-dispersing factor in Drosophila.Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity.DNA lesion-specific co-localization of the Mre11/Rad50/Nbs1 (MRN) complex and replication protein A (RPA) to repair foci.Genomic-anatomic evidence for distinct functional domains in hippocampal field CA1.A history of alcohol dependence increases the incidence and severity of postoperative cognitive dysfunction in cardiac surgical patients.The Ddc1-Mec3-Rad17 sliding clamp regulates histone-histone chaperone interactions and DNA replication-coupled nucleosome assembly in budding yeastLocking the DNA topoisomerase I protein clamp inhibits DNA rotation and induces cell lethality.Prolylcarboxypeptidase regulates proliferation, autophagy, and resistance to 4-hydroxytamoxifen-induced cytotoxicity in estrogen receptor-positive breast cancer cells.Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levelsThe synergistic effect of acupuncture and computer-based cognitive training on post-stroke cognitive dysfunction: a study protocol for a randomized controlled trial of 2 × 2 factorial design.The G-protein regulator AGS3 controls an early event during macroautophagy in human intestinal HT-29 cells.Catalytic activation of histone acetyltransferase Rtt109 by a histone chaperone.Fiber density between rhinal cortex and activated ventrolateral prefrontal regions predicts episodic memory performance in humansCholinergic plasticity in the hippocampus.Type 2 diabetes is negatively associated with Alzheimer's disease neuropathologyHistone Deacetylase Inhibitors (HDACi) Cause the Selective Depletion of Bromodomain Containing Proteins (BCPs).Retrospective and prospective responses arising in a modeled hippocampus during maze navigation by a brain-based deviceRisk of Alzheimer's disease incidence attributable to vascular disease in the populationAlzheimer's disease is a vasocognopathy: a new term to describe its nature.The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease.Advanced asymptomatic carotid disease and cognitive impairment: an understated link?Structural basis for inhibition of the histone chaperone activity of SET/TAF-Iβ by cytochrome c.Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Krüppel-like factor 5.Activation of group II metabotropic glutamate receptors inhibits glutamatergic transmission in the rat entorhinal cortex via reduction of glutamate release probability.Bilateral common carotid artery ligation transiently changes brain lipid metabolism in rats.Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse modelPin1-dependent prolyl isomerization modulates the stress-induced phosphorylation of high molecular weight neurofilament protein.Hippocampal and parahippocampal volumes in schizophrenia: a structural MRI study.Electroacupuncture improves cognitive ability following cerebral ischemia reperfusion injury via CaM-CaMKIV-CREB signaling in the rat hippocampus.Social ties and cognitive recovery after stroke: does social integration promote cognitive resilience?Active site mutations in DNA topoisomerase I distinguish the cytotoxic activities of camptothecin and the indolocarbazole, rebeccamycin.Two novel Xenopus homologs of mammalian LP(A1)/EDG-2 function as lysophosphatidic acid receptors in Xenopus oocytes and mammalian cells.Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility.A two-drug model for etoposide action against human topoisomerase IIalpha.The downregulation of the RNA-binding protein Staufen2 in response to DNA damage promotes apoptosis.
P2860
Q24299998-89D639C1-ED13-43BC-87C2-F28E384CF6E1Q24555147-9256555D-D301-4FD5-B091-04023017B742Q24629331-6ED55F55-D33B-4821-B8F5-1298E08FCE5CQ28513869-1B5EC7E8-5D63-4B0B-A196-4E1D63F19B93Q30436425-491C2C22-D413-40E3-AAD8-40F9B46D799BQ30523922-EA295B97-CF93-4469-AB44-88B9287CE4D0Q30573574-B66901A6-9C86-47CC-9376-D11C1DB352BBQ33210943-AD50ACE4-41C8-475B-91B6-3D2BE2E51376Q33475541-9ECB9CF9-4429-42FA-868D-79A8918E677AQ33565692-CCD62C85-AA02-40D7-8060-8D72AE83AAEEQ33675748-E9F7E108-285B-49EC-9E8A-2BC0230E7127Q33712882-DB97F9C2-DF10-4BA4-A128-7BA90A895E8BQ33750907-004B7AD4-C961-48CB-992F-EFD6C494E500Q33773714-B587B261-021B-4AA8-A407-169E5FCF0B1CQ34045857-8C5F00C2-4AC2-4525-A473-9555153A64ACQ34184261-CE470768-DF53-49C1-87CE-D2B3A6D0A667Q34377661-E55AD00F-A2A2-445A-839C-3A4B33792C90Q34750058-6C81F20B-B8CC-486D-9E36-6119378845F5Q34808959-2A3D097D-666F-4508-9775-0836095C1C06Q35184690-C79B7849-FB18-4A90-9D56-D1FFE2F053CFQ35583360-D15045FD-3E07-4B66-82AF-A0D8B81E075DQ35646986-FC966152-FA9E-40FC-B0A1-A820529E9AE0Q35792754-4F938E71-A202-4112-9456-660E7C0B7F2AQ35841706-316F6AAA-4AA6-4CC9-87FA-178DD97FCA45Q35841731-E0A6BE5D-D186-468B-A7C4-962B5077CB5BQ35897816-815B13DC-697A-4EDB-AD25-E09EFC1743C0Q35961467-5F977CD5-E106-4148-965C-B9D85AC959D9Q36023622-F403E9C3-915B-49FC-A6DD-BD20864EC61BQ36257149-7E2091F3-AE80-4751-A49E-3FA2F2629788Q36338190-2F086102-CB94-48CE-9005-DE2C15EAFB49Q36531841-6A7BE6BA-1ECD-47CF-8938-50D6B3A763FEQ36897651-6C26A411-5CA8-4D0B-98C4-F4FC59BAAFECQ37075810-B013A566-E49A-426B-A910-5ACC15C079EBQ37108195-C7A0E650-7F3E-4758-82A1-BD9C19D74EB5Q37477926-122338DE-E8E1-4FCF-8908-418F1F6DC308Q38293789-224982F3-B524-479B-9556-C29990DB13D3Q38302546-C7F427EE-7C2F-4DF2-9081-D7C0E74C28C3Q38342979-3043536F-6D6D-4522-B91C-5D282BE47A07Q38359958-EFFA4F31-935E-4761-B109-9760A8E73992Q38796786-1ED2AEA0-51D6-4940-AEAE-D8E812D0AADB
P2860
Vascular factors in cognitive impairment--where are we now?
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Vascular factors in cognitive impairment--where are we now?
@ast
Vascular factors in cognitive impairment--where are we now?
@en
type
label
Vascular factors in cognitive impairment--where are we now?
@ast
Vascular factors in cognitive impairment--where are we now?
@en
prefLabel
Vascular factors in cognitive impairment--where are we now?
@ast
Vascular factors in cognitive impairment--where are we now?
@en
P2860
P1476
Vascular factors in cognitive impairment--where are we now?
@en
P2093
P2860
P356
10.1111/J.1749-6632.2000.TB06343.X
P407
P577
2000-04-01T00:00:00Z